MDD EU Homepage Banners 2022

Welcome to the 7th Microbiome Movement - Drug Development Summit Europe

From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases. With more indications being pursued, and more trials being run than ever before, our ability as a community to overcome challenges around safety, delivery and commercialisation will define the next stage of microbiome drugs.

Returning to London in January, the 7th Microbiome Movement- Drug Development Summit Europe will unite Europe’s leading drug developers and microbiome experts to share their latest discoveries on microbiome functionality, translation, clinical development, biomarker discovery and manufacturing scale-up. As we return face-to-face, the 2023 summit will foster collaboration among clinicians, researchers, and industry.

Don’t miss this opportunity to get together in person to form vital partnerships that can turn microbiome science into business!

40+ Expert Speakers Including:

Chrysi Sergaki

Principal Investigator - Microbiome Group Leader

MHRA

Georges Rawadi

Chief Biotech Studio Development

EureKARE

Isabelle De Cremoux

Chief Executive Officer

Seventure Partners

James McIlroy

Founder & Chief Executive Officer

EnteroBiotix

Kristin Wannerberger

Director R&D Alliance Management

Ferring Pharmaceuticals

Natalie D’Amore

Head of External Innovation

Seres Therapeutics

Rodrigo Bacigalupe

Head of Microbiome and Disease, Discovery Data Science

GSK

Hear What Our Customers Say

"We need to combine our efforts to accelerate the knowledge and translation into the clinic, and the Microbiome Movement is offering exactly what we are needing."

- Institut Gustave Roussy

"In a field with many conferences of varying quality, the Microbiome Drug Development Summit consistently delivers substantive and compelling conversations and a collaborative vibe"

Celcius Therapeutics

Other Events In The Series